ada guidelines glp 1 for Diabetes 2026 #ada #diabetes @dr_samia_asim 2026 Diabetes Treatment Guidelines Update:

20.8% said they went through a weight loss clinic/program

Novo Nordisk is the market leader: Ozempic (weekly injection for type 2 diabetes) Wegovy (higher-dose weekly injection for obesity) Rybelsus ( Oral tablets for diabetes Oral tablets for weight management is in phase 3 trials) Eli Lilly is the other major player: Mounjaro (weekly injection for type 2 diabetes) Zepbound (higherdose weekly injection for obesity) This duopoly meant that both stocks had an incredible run-up from 2020 to 2024

The START-SYNERGY trial will enroll ~180 patients across 9 countries, including the US, South Africa, Serbia, Poland, Czech Republic, Spain, Netherlands, Bulgaria, and Hungary, evaluating ELV001 as an oral add-on therapy to standard care

Chronic central (intracerebroventricular) or peripheral (subcutaneous) infusion of GIP analogue in mice increased cFos neuronal activity in hypothalamic feeding center, resulting in reduced food intake and body weight